Catalyst Pharmaceuticals ... (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

24.32

0.03 (0.12%)

At close: May 01, 2025, 3:59 PM

23.78

-2.24%

After-hours: May 01, 2025, 07:47 PM EDT

Catalyst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	491.73M	398.2M	214.2M	140.83M	119.07M	102.31M	500K	n/a	n/a
Cost of Revenue	68.84M	84.53M	34.39M	21.88M	17.04M	14.76M	19.92M	45.69K	43.41K
Gross Profit	422.89M	313.67M	179.81M	118.95M	102.03M	87.55M	-19.42M	-45.69K	-43.41K
Operating Income	195.12M	86.81M	101.84M	52.38M	41.3M	31.82M	-35.3M	-18.68M	-19.28M
Interest Income	n/a	n/a	n/a	282K	587K	1.59M	1.29M	454.16K	321.61K
Pretax Income	216.26M	94.51M	104.72M	52.67M	41.89M	33.41M	-34M	-18.41M	-18.07M
Net Income	163.89M	71.41M	83.08M	39.48M	74.98M	31.88M	-34M	-18.41M	-18.07M
Selling & General & Admin	177.74M	133.71M	58.18M	49.63M	44.23M	36.88M	15.88M	7.3M	7.91M
Research & Development	12.65M	93.15M	19.79M	16.94M	16.5M	18.84M	19.92M	11.38M	11.37M
Other Expenses	37.38M	n/a	2.88M	282K	586.9K	1.59M	1.29M	454.16K	321.61K
Operating Expenses	227.76M	259.43M	77.97M	66.56M	60.73M	55.72M	35.8M	18.68M	19.28M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	1.29M	454.16K	321.61K
Selling & Marketing Expenses	111.34M	86.69M	29.47M	26.15M	23.57M	3.3M	n/a	n/a	n/a
Cost & Expenses	296.61M	311.39M	112.36M	88.45M	77.77M	70.48M	35.8M	18.68M	19.28M
Income Tax Expense	52.37M	23.1M	21.64M	13.19M	-33.09M	1.53M	2.58M	141.22K	-929.54K
Shares Outstanding (Basic)	118.46M	106.28M	103.37M	103.38M	103.51M	102.94M	102.63M	85.8M	82.88M
Shares Outstanding (Diluted)	124.94M	113.75M	111.38M	107.8M	106.24M	106.02M	102.63M	85.8M	82.88M
EPS (Basic)	1.38	0.67	0.80	0.38	0.72	0.31	-0.33	-0.21	-0.22
EPS (Diluted)	1.31	0.63	0.75	0.37	0.71	0.30	-0.33	-0.21	-0.22
EBITDA	232.9M	119.69M	101.84M	52.38M	41.3M	31.82M	-35.26M	-18.49M	-18.03M
EBIT	195.12M	86.81M	104.72M	52.67M	41.89M	33.41M	-35.3M	-18.41M	-18.07M
Depreciation & Amortization	38.05M	32.88M	1.49M	484K	885.32K	297.73K	37.98K	45.69K	43.41K